Quantcast

Supreme Court rejects generic drug labeling suits

By Reuters
Thursday, June 23, 2011 10:50 EDT
google plus icon
supremecourt_1298471071032-1-0-300x204
 
  • Print Friendly and PDF
  • Email this page

WASHINGTON (Reuters) – The Supreme Court ruled on Thursday that generic drug companies cannot be sued under state law over allegations that they failed to provide adequate label warnings about potential side effects.

The justices handed a victory to Israel’s Teva Pharmaceutical Industries Ltd, Mylan Inc’s UDL Laboratories and Iceland-based Actavis Inc by overturning U.S. appeals court rulings that allowed such lawsuits.

(Reporting by James Vicini, Editing by Gerald E. McCormick)

Reuters
Reuters
Reuters.com brings you the latest news from around the world, covering breaking news in business, politics, technology, and more.
 
 
 
 
By commenting, you agree to our terms of service
and to abide by our commenting policy.
 
Google+